MDXG vs VLTO · P/E 18, rev $123.4M vs P/E 29, rev $5.50B
MiMedx Group Inc (MDXG) versus Veralto Corporation (VLTO) — a side-by-side from cached financials, not a winner call.
MiMedx Group Inc (MDXG) is a biotechnology company listed on US.
Veralto Corporation (VLTO) is a pollution & treatment controls company listed on US.
Latest reported MDXG revenue for 2026-06-30 was $123.4M. Net income was -$25.7M. MDXG currently screens at market cap $537.7M and trailing P/E 18.1.
Latest reported VLTO revenue for 2025-12-31 was $5.50B. Net income was $940.0M. Revenue was up 6.0% from 2024-12-31 to 2025-12-31. VLTO currently screens at market cap $25.26B and trailing P/E 29.1.
MDXG currently screens at market cap $537.7M and trailing P/E 18.1. VLTO currently screens at market cap $25.26B and trailing P/E 29.1.
Not investment advice. Open the MDXG and VLTO stock pages for the full models.
Not investment advice.